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The review by Jones captures the important roles played by nitrated proteins, lipids, and oligonucleotides in
biology and disease. Through the development of new chemical biology techniques, further advances in our
knowledge of these species will be made and therapeutic opportunities unearthed.Rocaglamides Targets Prohibitin 1 and 2
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Rocaglamides are natural anticancer products isolated from the Aglaia plant used in traditional Chinese medi-
cine. A target identification approach, taken by Polier et al., shows that Rocaglamides bind to PHB1/PHB2
and thereby inhibit CRaf-MEK-ERK signaling pathway in cancer cells.viii Chemistry & Biology 19, September 21, 2012Fragment Screening at GPCRs in the Native
Environment
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G protein-coupled receptors are important drug targets, and initiatives
that measure ligand affinity in the native cellular environment are
required. Stoddart et al. report a live cell, high content, fluores-
cence-based assay to measure ligand affinity at human adenosine-
A1 and -A3 receptors.Giant Plasmid Carries Esmeraldin Gene Cluster
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The esmeraldin biosynthetic gene cluster was identified on a dispens-
able giant plasmid in Streptomyces antibioticus Tu¨ 2706. Rui et al.
reveal the roles of several enzymes from this cluster: EsmA1 and A2,critical for phenazine-1,6-dicarboxylic acid (PDC) formation; EsmB1-B5, which convert PDC to 6-acetylphena-
zine-1-carboxylic acid; and EsmD1-D3, which carry out esterification of target compounds.Hormones as Obesity Fighters
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The androgen receptor (AR) affects fat distribution in men and women.
Hartig et al. report that AR expression is unique to the early phases of
human fat maturation and regulated by glucocorticoid. Manipulation
of the androgen/glucocorticoid axis may help correct fat deposition
defects in lipid storage disorders.New in MS Treatment
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A Sphingosine 1-phosphate receptor-1 (S1P1) agonist, Fingolimod
(FTY720, Gilenya), has recently been approved for the treatment of
multiple sclerosis (MS). Quancard et al. describe NIBR-0213, a potent
and selective S1P1 antagonist that shows comparable therapeutic
efficacy to fingolimod in a mouse model of MS.ª2012 Elsevier Ltd All rights reserved
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Busschots et al. describe small molecules that bind to the PIF-pocket of PDK1 and allosterically close the kinase
domain in an active conformation. In cells, however, the compounds are substrate-selective inhibitors that
inhibit the phosphorylation of S6K but do not affect PKB/Akt activation.Bongkrekic Acid Biosynthesis
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Bongkrekic acid (BA) is a respiratory toxin of the bacterium Burkholde-
ria gladioli. Moebius et al. unveil the genetic basis for BA biosynthesis
and provide insights into modular type I PKS and polyketide assembly,
involving isoprenoid-like b-branching and a six-electron oxidation of
a terminal methyl group.Overcoming Leukemia Cell Survival
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MCL-1 has an emerging role as a drug target for a broad range of
human cancers. Cohen et al. use a natural MCL-1 antagonist, the
BH3 domain of MCL-1 itself, to identify MCL-1 inhibitor molecule 1
(MIM1). They validate MIM1 as a selective MCL-1 antagonist capable
of blocking MCL-1-dependent suppression of apoptosis.Cancer Cells Addicted to Serine
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Kung et al. report molecules that activate the glycolytic enzyme PKM2
and add to a growing appreciation for the importance that cancer cells
place on maintaining their access to serine. In the PKM2 off state,
glycolytic intermediates are diverted to make serine, and in the PKM2
on state, serine becomes an essential amino acid.Imaging Inflammatory Phagocytes
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Inflammation is a complicated biological process which can be divided
into acute and chronic stages. Tseng and Kung describe a biolumines-
cence imaging method to distinguish inflammation status in living
animals based on the use of luminal to image acute and lucigenin to
image areas with chronic inflammation.Chemistry & Biology 19, September 21, 2012 ª2012 Elsevier Ltd All rights reserved ix
